Analyzing Catamaran Corp (SXCI) & Its Competitors
Catamaran Corp (NASDAQ: SXCI) is one of 14 publicly-traded companies in the “Managed Health Care” industry, but how does it contrast to its peers? We will compare Catamaran Corp to similar companies based on the strength of its earnings, valuation, institutional ownership, risk, analyst recommendations, profitability and dividends.
This table compares Catamaran Corp and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Catamaran Corp Competitors||1.81%||11.04%||3.55%|
This is a breakdown of recent recommendations for Catamaran Corp and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Catamaran Corp Competitors||81||931||1473||24||2.57|
As a group, “Managed Health Care” companies have a potential downside of 1.85%. Given Catamaran Corp’s peers higher possible upside, analysts plainly believe Catamaran Corp has less favorable growth aspects than its peers.
Insider and Institutional Ownership
90.7% of shares of all “Managed Health Care” companies are owned by institutional investors. 2.6% of shares of all “Managed Health Care” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Catamaran Corp and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Catamaran Corp Competitors||$50.73 billion||$1.52 billion||11.48|
Catamaran Corp’s peers have higher revenue and earnings than Catamaran Corp. Catamaran Corp is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Risk & Volatility
Catamaran Corp has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500. Comparatively, Catamaran Corp’s peers have a beta of 0.61, suggesting that their average stock price is 39% less volatile than the S&P 500.
Catamaran Corp peers beat Catamaran Corp on 7 of the 8 factors compared.
About Catamaran Corp
Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government’s Medicare Part D program. The Company’s HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.
Receive News & Ratings for Catamaran Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.